van der Biessen, Diane A. J.
Gietema, Jourik A.
de Jonge, Maja J. A.
Desar, Ingrid M. E.
den Hollander, Martha W.
Dudley, Matthew
Dunbar, Martin
Hetman, Robert
Serpenti, Camille
Xiong, Hao
Mittapalli, Rajendar K.
Timms, Kirsten M.
Ansell, Peter
Ratajczak, Christine K.
Shepherd, Stacie Peacock
van Herpen, Carla M. L.
Funding for this research was provided by:
AbbVie
Article History
Received: 20 November 2017
Accepted: 12 December 2017
First Online: 8 January 2018
Compliance with ethical standards
: This study was conducted in accordance with the protocol, International Conference on Harmonization Good Clinical Practice guidelines, applicable regulations and guidelines governing clinical study conduct, and ethical principles that have their origin in the Declaration of Helsinki. The study has been approved by the local ethics committees.
: DAJvdB, JAG, MJAdJ, IMED, MWdH, and CMLvH have no conflicts of interest to declare.KMT is a Myriad employee and may own Myriad stock. M Dudley, M Dunbar, RH, CS, HX, RKM, CKR, and PA are AbbVie employees and may own AbbVie stock. SPS was an AbbVie employee at time of study and may own AbbVie stock.
: Patients provided written informed consent before participation in the trial.